$BCRX so they hit their Q4 numbers, had stellar phase IA results and guided for a 70Mil increase in revenue in 202e.

$BCRX energy cost down, food cost increases declined amongst other. https://www.bls.gov/news.release/cpi.t01.htm

50 basis point increase this week should give the markets a relief rally!

That's an increase of 2.3% over a year ago – surpassing the previous online Black Friday sales high mark of $9.03 billion in 2020.

This is a 84.91 percent increase over sales of $40.99 million the same period last year.

The combination of ACP-01 AND NCP-01 is targeted to decrease pain and increase functionality.

As I mentioned, I wasn't expecting too much from this conference - seeing a 3% increase is great

$AVXL More excitement here than with $BIIB Approval and no big price increase.

First drug to show INCREASE in Cognition.

Very easy to calculate the huge increase %, in the SP tomorrow.

We will only see a slight increase on great data.

We might reach 50% increase on Thursday to $13 or $14.

Increases in personnel is big bullish to me.

The upcoming stock increase will allow us to spread our money around in other good ways. 4.

:-) btw interesting steep increase in 22 Q2.

Sales improving, patent safe, patent extension 2037, increase in insurance covering.

Once again the shorts gained .01 cent with an increase of 14.9% over January.

I think it’s just consistent script number increase WoW/MoM.

This is an increase of greater than 75% versus 2021 and an improvement of approximately 13% over Q3.

Sales increase.

• 97% gross margin (sheesh) • Excited bout new partnership(details soon) • drug price increase • 85% conversion psf's (stellar) • Tam is there, huge growth opportunity if they can get more sle patients tested, 75% would capture many.

$AUPH Institutional position increase in the past few weeks = bullish.

Increase of .25%.